Human Fetal Stem Cell Therapy

Human Fetal Stem Cell Therapy is a medical treatment whereby human Fetal Stem Cells (“mother” cells of the body) are transplanted into a patient. These cellular building blocks are usually administered intravenously (Fetal pluripotent hematopoietic stem cells) and subcutaneously (Fetal neuronal stem cells). It is a painless procedure, which takes place in approximately one hour, with no negative side effects.
The Fetal Stem Cell searches out, detects and then attempts to repair any damage or deficit discovered, as well as releases growth factors, which stimulate the body’s own repair mechanisms.

Fetal Cell Properties

· Human Fetal Stem Cell Therapy can be compared to a bone marrow transplant, which is known to be a successful treatment for a variety of malignant, autoimmune and genetic diseases. The primary advantage of Fetal Stem Cell transplantation is that unlike a traditional bone marrow, or umbilical cord blood stem cell transplant, there is no need for the difficult and at times futile attempt to find a donor match.

· The Fetal Stem Cell does not have antigenicity (a cellular fingerprint) therefore they can be given to anyone without any rejection phenomena, thereby eliminating the use of immunosuppressive therapy (drugs that suppress the much needed immune system).

· Graft versus Host Reaction (where the donor cells attack the recipient, a dangerous and potentially fatal complication of bone marrow and umbilical cord transplantation) does not exist in Fetal Stem Cell therapy.

· Due to their controlled ability to rapidly proliferate, and their immediate release of growth factors, the Fetal Stem Cells are capable of, at times, quickly reversing lost functions.

These properties of the Fetal Stem Cell allow for unique treatment intervention in a multiplicity of diseases for a large group of patients who up until now have not had any means for recovery.

Patient Benefits

A large number of patients have been treated with Fetal Stem Cell Therapy, with by current standards, remarkable physical and psychological improvements.The range of human diseases currently viewed as candidates for fetal stem cell therapy is enormous and is continually expanding.Although it is still considered to be an experimental treatment in the United States, Human Fetal Stem Cell Therapy has been performed in other countries. Medra, Inc. can make the arrangements for receiving the Human Fetal Stem Cell Treatment. At the present time the therapy is administered in the Dominican Republic. (A one hour and forty-five minute flight from Miami.)Rarely has a single treatment modality offered so much promise to those suffering from some of mankind’s worst afflictions.